Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | W69* | Nonsense | 2 |
| BLCA | Bladder urothelial carcinoma | D236N | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | L96M | Missense | 1 |
| CESC | Cervical and endocervical cancers | L182L | Silent | 1 |
| COAD | Colon adenocarcinoma | G288G | Silent | 1 |
| COAD | Colon adenocarcinoma | G312D | Missense | 1 |
| ESCA | Esophageal carcinoma | R87* | Nonsense | 1 |
| KIRC | Kidney renal clear cell carcinoma | P46P | Silent | 1 |
| LGG | Brain Lower Grade Glioma | S115S | Silent | 1 |
| LUAD | Lung adenocarcinoma | L163L | Silent | 1 |
| LUAD | Lung adenocarcinoma | L182L | Silent | 1 |
| LUAD | Lung adenocarcinoma | P291R | Missense | 1 |
| LUSC | Lung squamous cell carcinoma | K200N | Missense | 1 |
| PAAD | Pancreatic adenocarcinoma | S325I | Missense | 1 |
| PCPG | Pheochromocytoma and Paraganglioma | R161Q | Missense | 1 |
| PRAD | Prostate adenocarcinoma | E49D | Missense | 1 |
| PRAD | Prostate adenocarcinoma | P244L | Missense | 1 |
| SARC | Sarcoma | P276S | Missense | 1 |
| SARC | Sarcoma | S155F | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | L102L | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | P241S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P280L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | T20T | Silent | 1 |
| STAD | Stomach adenocarcinoma | G288G | Silent | 1 |
| STAD | Stomach adenocarcinoma | G289R | Missense | 1 |
| STAD | Stomach adenocarcinoma | G312D | Missense | 1 |
| STAD | Stomach adenocarcinoma | R45R | Silent | 1 |
| STAD | Stomach adenocarcinoma | R9H | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 0 | 12.5 | 66.7 |
| BRCA | Breast invasive carcinoma | 976 | 0 | 0 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 10 | 0 | 0 |
| COAD | Colon adenocarcinoma | 367 | 10 | 6.2 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 0 | 33.3 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 0 | 0 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 10 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 10 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 0 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 20 | 6.2 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 6.2 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 6.2 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 6.2 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 12.5 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 12.5 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 20 | 12.5 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 20 | 18.8 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 0 | 0 | 0 |